Women who are pregnant or breastfeeding
Pregnant or breastfeeding women
Woman who are pregnant or breastfeeding
Pregnant or breastfeeding.
Females who are pregnant or breastfeeding
Currently pregnant or breastfeeding
Pregnant or breastfeeding
Patients who are pregnant or breastfeeding are excluded from the study
Women who are breastfeeding or pregnant as evidenced by a positive pregnancy test within 14 days of first dose.
18. Pregnancy or breastfeeding women.
Women who are pregnant or breastfeeding.
Women who are pregnant or breastfeeding (unless the patient is willing to interrupt breastfeeding during study treatment administration and then resume 6 months after study discontinuation); women of childbearing potential must not consider getting pregnant during the study
Women must not be breastfeeding.
Patient is pregnant or breastfeeding
Women who are pregnant or breastfeeding.
Pregnant or breastfeeding, or intending to become pregnant during the study
Pregnant or breastfeeding.
Pregnant or breastfeeding women
Patients may not be pregnant or breastfeeding
Women must not be breastfeeding
Women must not be breastfeeding
Pregnant or breastfeeding females
Pregnant or breastfeeding women
Patient is pregnant or breastfeeding
Females who are pregnant (positive urine test) or breastfeeding
Pregnant female patients; breastfeeding female patients; male patients with partners currently pregnant.
Is a female subject who is pregnant or breastfeeding.
Pregnant or breastfeeding
Pregnant or breastfeeding women.
Pregnant women or women who are breastfeeding
Pregnant or breastfeeding.
Pregnant or breastfeeding
Females who are pregnant or breastfeeding
Patients who are pregnant or breastfeeding
Pregnant or breastfeeding female patients
Pregnant or breastfeeding women will be excluded from participation in this trial
Are pregnant or breastfeeding.
Is not pregnant or breastfeeding
Females who are pregnant or breastfeeding
Women must not be pregnant or breastfeeding
Pregnant or breastfeeding females.
Female subjects of childbearing potential must not be pregnant or breastfeeding
Pregnant or breastfeeding female.
Patients must not be pregnant or breastfeeding
Pregnant and/or breastfeeding
Females only: pregnant or breastfeeding
Pregnant or breastfeeding
If female, is pregnant, breastfeeding, or planning to become pregnant.
Pregnant or breastfeeding women.
Pregnant or breastfeeding.
Currently pregnant or breastfeeding
Pregnant or breastfeeding women, or intending to become pregnant during the study
Subject is pregnant or breastfeeding.
Breastfeeding or pregnant.
Women who are pregnant or breastfeeding.
Pregnant or breastfeeding, or intending to become pregnant during the study
If female, is pregnant, breastfeeding, or planning to become pregnant.
Female subject who is pregnant or breastfeeding.
If female, subject is pregnant and/or breastfeeding.
Breastfeeding
Women who are pregnant or breastfeeding
Female patients may not be pregnant or breastfeeding
Subjects that are pregnant or breastfeeding an infant.
Pregnant or breastfeeding
Pregnant women and women who are breastfeeding are excluded from this study
Pregnant or breastfeeding
Women who are breastfeeding and who are unwilling to stop breastfeeding prior to study entry
Pregnant or breastfeeding women
Pregnant or breastfeeding women
Patient must not be pregnant or breastfeeding
Pregnant or breastfeeding
Pregnant or breastfeeding
Females must not be breastfeeding
Women must not be breastfeeding.
Pregnant or breastfeeding females.
Women must not be breastfeeding
Women who are breastfeeding
Females who are pregnant or breastfeeding
Currently pregnant or breastfeeding
Women of childbearing potential who are pregnant or breastfeeding
Patients that are pregnant or breastfeeding
Women who are breastfeeding.
Women who are pregnant or breastfeeding
Women must not be breastfeeding.
Female patients who are pregnant or breastfeeding
Pregnant or breastfeeding, or intending to become pregnant during the study or within 140 days after the last dose of BTRC4017A
Pregnant or breastfeeding.
Females who are pregnant or breastfeeding
Participants who are women must not be breastfeeding
Pregnant or breastfeeding
Women must not be breastfeeding.
Pregnant or breastfeeding.
Inability or refusal to practice effective contraception during therapy or the presence of pregnancy or active breastfeeding; pregnant or breastfeeding women will be excluded from participation in this trial
Pregnant women and women who are breastfeeding are excluded from this study
Women who are pregnant or breastfeeding
Females who are pregnant or breastfeeding.
Pregnancy, breastfeeding, or intention of becoming pregnant during the study
Pregnant or breastfeeding
Female participants who are pregnant or breastfeeding are excluded.
Females who are pregnant or breastfeeding.
Pregnant or breastfeeding female patients
Pregnant or breastfeeding.
Women must not be pregnant (as above) or breastfeeding
Pregnant or breastfeeding, or intending to become pregnant during the study
Pregnant or breastfeeding
Women must not be pregnant (as above) or breastfeeding
Female patients who are pregnant or breastfeeding
Females who are pregnant or breastfeeding or planning to become pregnant within 90 days after their last anticipated dose of BCV
The participant is pregnant or breastfeeding
Women who are pregnant or breastfeeding.
Women must not be breastfeeding.
Pregnant or breastfeeding females
Patients who are pregnant or breastfeeding
Patients who are pregnant or breastfeeding
Are females who are pregnant or breastfeeding.
Women who are pregnant or breastfeeding
Women must not be breastfeeding.
Females must not be breastfeeding
Pregnant or breastfeeding
Patient is pregnant or breastfeeding
Women must not be breastfeeding.
WOCBP who are pregnant or breastfeeding.
Women who are breastfeeding
Pregnant, breastfeeding, or plan to become pregnant during the study duration
HEALTHY SUBJECT: Not pregnant or breastfeeding
Female subjects who are pregnant, are planning on becoming pregnant, or are currently breastfeeding.
Women must not be breastfeeding
Women who are pregnant or breastfeeding
Pregnant or actively breastfeeding women
Women who are pregnant or breastfeeding
Subject is pregnant or breastfeeding.
Pregnant and/or breastfeeding
Women must not be breastfeeding
DONOR: WOCBP: Pregnant or =< 6 months breastfeeding
Female patients who are pregnant or breastfeeding; breastfeeding should be discontinued
Pregnant or breastfeeding women are excluded from this study
Women must not be breastfeeding
CRITERIA FOR SCREENING: Pregnant or breastfeeding women
Women must not be breastfeeding
Women who are pregnant or breastfeeding
Pregnant or breastfeeding women;
Pregnant or breastfeeding
Women must not be breastfeeding
Pregnant and/or breastfeeding
DONOR: Pregnant and/or breastfeeding
Pregnant or breastfeeding women
Subjects who are pregnant or breastfeeding.
Women who are pregnant or breastfeeding
Pregnant women and breastfeeding mothers are excluded
Females who are pregnant or are currently breastfeeding
Patients who are pregnant or breastfeeding
Pregnant or breastfeeding females
Breastfeeding females
Women must not be breastfeeding
Patients who are pregnant, are lactation, or breastfeeding
Pregnant or breastfeeding females
Breastfeeding or pregnant
Pregnant or breastfeeding women
Women who are pregnant or breastfeeding
Women who are pregnant or breastfeeding
Pregnancy, breastfeeding or possibility of becoming pregnant during the study.
Is pregnant or breastfeeding
Women who are breastfeeding
Women of childbearing potential who are pregnant or breastfeeding
Pregnant or breastfeeding
Pregnant or breastfeeding
Females who are pregnant or breastfeeding.
Women must not be breastfeeding
Women who are of pregnant or breastfeeding
The patient is pregnant or is breastfeeding.
Women who are pregnant or breastfeeding; women who agree to stop breastfeeding would be eligible
Patients who are pregnant or breastfeeding will be excluded from the study
Subjects who are pregnant or breastfeeding are excluded
Pregnant or breastfeeding (female only)
Pregnant and/or breastfeeding
DONOR: Pregnant and/or breastfeeding
Females must not be breastfeeding
Pregnant or breastfeeding
Pregnant and breastfeeding women are excluded.
Pregnant or breastfeeding
Is pregnant or breastfeeding
Pregnant or breastfeeding women
Pregnant or breastfeeding women
Pregnant or breastfeeding females.
Women who are pregnant or breastfeeding
Female subjects who are breastfeeding, pregnant, or plan to become pregnant during the study or within 3 months following the last dose of investigational product
Pregnant or breastfeeding
Women who are pregnant, or who are currently breastfeeding
Women who are pregnant or breastfeeding.
Pregnant or breastfeeding women.
Women must not be breastfeeding
Breastfeeding women.
Women who are pregnant or breastfeeding
DONOR: Pregnant or breastfeeding
Pregnant or breastfeeding
Pregnant or breastfeeding women are excluded from this study
Women who are pregnant or breastfeeding are excluded from the study
Pregnant or breastfeeding participants
Female subjects who are pregnant or breastfeeding
Women who are pregnant or breastfeeding
Women who are pregnant or breastfeeding
Women must not be breastfeeding
Pregnant or breastfeeding
Pregnant or breastfeeding
ADDITIONAL CRITERIA FOR STUDY CONTINUATION: Pregnant or breastfeeding
Pregnant or breastfeeding women are excluded from this study
Patient is pregnant or breastfeeding
Pregnant or breastfeeding
Pregnant or breastfeeding.
Women who are pregnant or breastfeeding
Pregnant or breastfeeding
Pregnant or breastfeeding
PART 1: Pregnant or breastfeeding
PART 2: Pregnant or breastfeeding
Women who are pregnant or breastfeeding
Women must not be breastfeeding
Pregnant or breastfeeding
Women who are pregnant or breastfeeding
Pregnant or breastfeeding women are excluded from this study
Patients who are pregnant or breastfeeding
The subject is pregnant or breastfeeding
Pregnant or breastfeeding women are excluded from this study; breastfeeding should be discontinued
Females who are pregnant or breastfeeding
Women who are breastfeeding
Pregnant women are excluded from this study; breastfeeding should also be avoided
The subject is pregnant or breastfeeding
Women who are pregnant or breastfeeding
Pregnant or breastfeeding
Pregnant and/or breastfeeding
Pregnant and breastfeeding women are excluded from this study
Pregnant or breastfeeding
Women who are pregnant or breastfeeding
Patients who are pregnant or breastfeeding
Patient must not be pregnant or breastfeeding
Pregnant women are excluded from this study; breastfeeding should also be avoided
Females who are pregnant or are currently breastfeeding
Women who are pregnant or breastfeeding
Pregnant or breastfeeding
Are pregnant or breastfeeding.
Patients who are pregnant or breastfeeding are excluded from the study
Female patients who are pregnant or breastfeeding
Women who are pregnant or breastfeeding.
Pregnant or breastfeeding female
Pregnant or breastfeeding woman.
Pregnant or breastfeeding
Participant is pregnant or is a breastfeeding female
Women must not be breastfeeding
Patients who are currently pregnant or breastfeeding.
Are pregnant or breastfeeding
Female patients who are breastfeeding.
Females must not be pregnant or breastfeeding
Women who are pregnant or breastfeeding.
Pregnant or breastfeeding women
Pregnant or breastfeeding
Pregnant or breastfeeding women.
Pregnant or breastfeeding women
Pregnant and/or breastfeeding
Females must not be breastfeeding
WOCBP: Pregnant or breastfeeding
Pregnant or is breastfeeding
Pregnant or breastfeeding
Patients who are pregnant or breastfeeding.
Patients who are pregnant or breastfeeding
Pregnant or breastfeeding female patients.
Pregnant or breastfeeding
Female only: pregnant or breastfeeding
Pregnant or breastfeeding
Pregnant or breastfeeding females.
Pregnant or breastfeeding females.
Pregnant or breastfeeding, or planning to become pregnant within 6 months after the end of treatment
Pregnant or breastfeeding females
Pregnant women are excluded from this study; breastfeeding should also be avoided
Pregnant or breastfeeding
Are female and pregnant or breastfeeding.
Pregnant or breastfeeding female.
Participants who are pregnant or breastfeeding
Women currently pregnant or breastfeeding
Female patient who is breastfeeding.
Women must not be breastfeeding
Women who are pregnant or breastfeeding
TUMOR BIOPSY SEQUENCING: Women who are pregnant or breastfeeding
TREATMENT: Women who are pregnant or breastfeeding
Women must not be pregnant (as above) or breastfeeding
Pregnant or breastfeeding patients are not eligible
Women who are pregnant or breastfeeding
Females must not be breastfeeding
Not breastfeeding
Pregnant or breastfeeding
Pregnant or breastfeeding
Female participants must not be breastfeeding
The subject is pregnant or breastfeeding
Female patients who are pregnant or breastfeeding
Females who are pregnant or breastfeeding
Pregnant or breastfeeding
Women who are pregnant or breastfeeding
Women who are pregnant or breastfeeding
Female subject who is pregnant or breastfeeding
Breastfeeding patients are ineligible
Pregnant or breastfeeding
Female patient who is pregnant or breastfeeding
Women who are breastfeeding
Women must not be pregnant or breastfeeding; breastfeeding must be discontinued or the subject is not eligible for the study
PHASE II: Women must not be pregnant or breastfeeding; breastfeeding must be discontinued or the subject is not eligible for the study
Patient must not be pregnant and/or breastfeeding
Pregnant or breastfeeding women
Pregnant or breastfeeding
Pregnant or breastfeeding
Women who are breastfeeding
The subject is pregnant or breastfeeding.
Subjects who are pregnant or breastfeeding.
Currently pregnant or breastfeeding
Females who are pregnant or breastfeeding; women of childbearing potential must not be considering getting pregnant during the study
Females who are pregnant, unable to comply with birth control use to avoid becoming pregnant or breastfeeding
Patients who are pregnant or breastfeeding.
Females who are pregnant or breastfeeding.
Pregnant or breastfeeding women.
Pregnant or breastfeeding women
Pregnant or breastfeeding
Breastfeeding or pregnant.
Pregnant or breastfeeding
Breastfeeding
Pregnant and breastfeeding women are excluded from this study
Pregnant or breastfeeding women.
Participants who are breastfeeding, or intending to become pregnant during the study
Pregnant or breastfeeding women
Pregnant or breastfeeding women
Pregnant or breastfeeding women
Females who are pregnant or breastfeeding
Women who are pregnant or breastfeeding
Is pregnant or breastfeeding.
Be pregnant, planning a pregnancy, or breastfeeding
Pregnant or breastfeeding women.
Pregnant or breastfeeding patients;
Pregnant or breastfeeding
Pregnant or breastfeeding.
Females who are pregnant or breastfeeding
Pregnant or breastfeeding woman or female who intends to become pregnant during the participation in the study.
Women must not be breastfeeding
are pregnant or breastfeeding
Breastfeeding or pregnant
Females who are pregnant or breastfeeding as well as all females of childbearing potential who:
Breastfeeding women.
Pregnant or breastfeeding
Women who are pregnant or breastfeeding
Pregnant or breastfeeding
Are pregnant or breastfeeding.
Women who are breastfeeding
Females who are pregnant or breastfeeding
Pregnant and/or breastfeeding
Women who are pregnant or breastfeeding
Subject is pregnant or breastfeeding or intends to get pregnant within 28 days of enrolling into the study.
Female patients who are pregnant or breastfeeding
Subject if female, is pregnant or breastfeeding
Women must not be breastfeeding.
Women who are pregnant or breastfeeding.
Women who are pregnant or breastfeeding.
Women must not be breastfeeding
Females who are pregnant or breastfeeding.
Women must not be breastfeeding at the time of study registration
Patients who are pregnant or breastfeeding
Is pregnant, breastfeeding, or planning a pregnancy
Women who are pregnant or breastfeeding
Current breastfeeding (females only)
Breastfeeding and pregnant.
Women must not be breastfeeding
Females who are pregnant or breastfeeding.
Breastfeeding or pregnant
Women must not be breastfeeding
WOCBP who are pregnant or breastfeeding
Pregnant and/or breastfeeding
Women who are breastfeeding.
Breastfeeding or pregnant
Pregnant or breastfeeding
Pregnant or breastfeeding women
Women who are pregnant or breastfeeding
Patients who are pregnant or breastfeeding
Women must not be pregnant or breastfeeding
Pregnant or breastfeeding females
Patient is pregnant or breastfeeding
Pregnant or breastfeeding women
Pregnant or breastfeeding
Female subjects that are pregnant or breastfeeding are not eligible
Pregnant or breastfeeding
Be pregnant or breastfeeding.
Breastfeeding
Women who are breastfeeding or pregnant
Pregnant or breastfeeding.
Are pregnant or breastfeeding
A participant who is pregnant or breastfeeding
Pregnant or breastfeeding women
Pregnant or breastfeeding
Patient is breastfeeding.
Pregnant or patients who are breastfeeding
Women who are pregnant or breastfeeding
Women who are breastfeeding or pregnant
Women must not be breastfeeding.
Women who are pregnant or breastfeeding
Is pregnant or breastfeeding
Breastfeeding women, pregnant women
Participant is pregnant or breastfeeding
PART B: Pregnant or breastfeeding women
Pregnant and/or breastfeeding
Pregnant or breastfeeding
Women who are pregnant or breastfeeding
Pregnant or breastfeeding.
The patient is pregnant or breastfeeding
Pregnant women or women who are breastfeeding are excluded from this study
Pregnant or breastfeeding
Pregnant or breastfeeding
Pregnant or breastfeeding
Pregnant or breastfeeding
Females who are pregnant or are currently breastfeeding
Pregnant or breastfeeding
Patient must not be pregnant and/or breastfeeding
Be a woman who is pregnant or breastfeeding
Must not be pregnant or breastfeeding.
Women must NOT be pregnant or breastfeeding
Women who are pregnant or breastfeeding
Patients who are pregnant or breastfeeding
The participant is pregnant or breastfeeding
Women who are pregnant or breastfeeding
Pregnant or breastfeeding
Pregnant or breastfeeding patients
Women who are pregnant or breastfeeding
Female patients who are pregnant or currently breastfeeding
Females must not be breastfeeding
Pregnant (positive ?-HCG) or breastfeeding.
Pregnant or breastfeeding; breastfeeding may not resume for 14 days after the last dose of pazopanib
Patients who are pregnant or breastfeeding
Pregnant, or actively breastfeeding females.
Female patients who are breastfeeding or pregnant
The subject is pregnant or breastfeeding
Patient is pregnant or breastfeeding
Women who are pregnant or breastfeeding
Pregnant or breastfeeding females
Pregnant or breastfeeding
EXPANSION COHORT ONLY: Pregnant or breastfeeding
Pregnant or breastfeeding women
Females who are pregnant or breastfeeding
Female patients who are pregnant or breastfeeding
Women who are pregnant or breastfeeding.
Patient is pregnant or breastfeeding
Women who are breastfeeding
Women who are pregnant or breastfeeding
Breastfeeding mothers
Women who are breastfeeding
Pregnant or breastfeeding patients
Pregnant or breastfeeding women
Pregnant women or females who are breastfeeding
Currently pregnant or breastfeeding.
Women who are breastfeeding
Breastfeeding or pregnant.
Women who are pregnant or breastfeeding
Women who are breastfeeding
Women who are pregnant or breastfeeding
Females who are pregnant or breastfeeding
Women who are pregnant or breastfeeding.
Women who are pregnant or breastfeeding
Women must not be breastfeeding
Women who are pregnant or breastfeeding
Women who are breastfeeding
The participant is pregnant, breastfeeding, or planning to become pregnant or father a child
Breastfeeding or pregnant
Female subjects that are pregnant or breastfeeding.
Women who are pregnant or breastfeeding
Are pregnant or breastfeeding
Women who are pregnant (including positive pregnancy test at enrollment or prior to study drug administration) or breastfeeding
Pregnant women and women who are breastfeeding are excluded from this study
Females who are pregnant or breastfeeding
16. Women who are pregnant or breastfeeding.
Women who are pregnant or breastfeeding.
Women that are pregnant or breastfeeding
Subject is currently pregnant or breastfeeding, or is planning to become pregnant during the study
Women must not be breastfeeding
Pregnant or breastfeeding females
Pregnant or breastfeeding women
Females who are pregnant or breastfeeding.
Women must not be breastfeeding
Are pregnant or breastfeeding.
Subject is pregnant or breastfeeding
Pregnant, breastfeeding, or planning to become pregnant during the study;
Women who are pregnant or breastfeeding
Females who are pregnant or breastfeeding.
Not breastfeeding
Women must not be breastfeeding
(Female only) not breastfeeding
(Female only) is not breastfeeding
Women must not be breastfeeding.
Participants who are pregnant or breastfeeding
Pregnant or breastfeeding women
Patients may not be pregnant or breastfeeding
Women who are breastfeeding or pregnant
The subject is pregnant or breastfeeding.
Pregnant or breastfeeding women are excluded from this study; breastfeeding should be discontinued
Women of childbearing potential who are pregnant or breastfeeding
Pregnant or breastfeeding
Is pregnant, breastfeeding, or planning a pregnancy
Women who are pregnant or breastfeeding.
Pregnant or breastfeeding
Pregnant or breastfeeding women
Pregnant or breastfeeding
Pregnant or breastfeeding.
Women who are breastfeeding
Pregnant or breastfeeding
Pregnant and/or breastfeeding
Is the subject breastfeeding?
Pregnant or breastfeeding
Females of childbearing potential who are not pregnant or breastfeeding
Patients who are pregnant or breastfeeding.
The subject is pregnant or breastfeeding
Female subjects who are pregnant or breastfeeding.
Pregnant or breastfeeding women.
Pregnant or breastfeeding women
Pregnant or breastfeeding women
Pregnant or breastfeeding women
Females must not be breastfeeding
Pregnant or breastfeeding
Pregnant or breastfeeding females
The subject is pregnant or breastfeeding
Pregnant or breastfeeding, or intending to become pregnant during the study
Females who are pregnant or breastfeeding
Women who are pregnant or breastfeeding
Pregnant or breastfeeding
Women must not be breastfeeding
Women who are pregnant or breastfeeding
Pregnant or breastfeeding women
Pregnant or breastfeeding females
Be pregnant or breastfeeding
Recipient must not be pregnant and/or breastfeeding.
Pregnant or breastfeeding females
Females who are pregnant or are breastfeeding.
The subject is pregnant or breastfeeding
Breastfeeding or pregnant females
Female subjects who are pregnant or breastfeeding.
Pregnant (positive total HCG) or breastfeeding
Pregnant or breastfeeding (women)
Women who are breastfeeding
Pregnant and/or breastfeeding
Women who are pregnant or breastfeeding
Pregnant or breastfeeding females
Female subjects who are pregnant, or breastfeeding, or planning to become pregnant. Male subjects who plan to father a child while enrolled in this protocol.
Pregnant, breastfeeding or considering becoming pregnant within 6 months following the last dose of investigational product;
Subject is pregnant or breastfeeding.
Pregnant or breastfeeding
Pregnant and/or breastfeeding
As per self-report participants who are pregnant or who are breastfeeding
Pregnant or breastfeeding
Pregnant and breastfeeding women are excluded from this study
Not pregnant or breastfeeding
Pregnant or breastfeeding
Pregnant and breastfeeding women are not eligible for thyroidectomy and so are excluded from this study
Pregnant or breastfeeding
For women: breastfeeding, pregnancy, or plan to become pregnant within 6 months
Patients who are pregnant or breastfeeding
Females who are pregnant or breastfeeding are ineligible
Female patients who are pregnant or breastfeeding
Pregnant or breastfeeding
Females who are pregnant or are currently breastfeeding
Pregnant or breastfeeding women; positive pregnancy test within 7 days of starting treatment
Females who are pregnant or breastfeeding
Females who are pregnant or breastfeeding;
Pregnant or breastfeeding
Women who are pregnant or breastfeeding
Pregnant or breastfeeding
Patient must not be pregnant and/or breastfeeding
Patient must not be pregnant and/or breastfeeding
Female subjects who are pregnant or breastfeeding
Female subjects who are pregnant or breastfeeding
Is pregnant or breastfeeding
Female who is pregnant or breastfeeding
Patients who are pregnant or breastfeeding
Women who are pregnant or breastfeeding
Participants who are breastfeeding are excluded
Women who are pregnant (positive serum or urine ?HCG) or breastfeeding
They are not breastfeeding;
Pregnant or intention to get pregnant, or breastfeeding; pregnant women are excluded from this study; women who are breastfeeding will be excluded
Currently breastfeeding.
Pregnant and/or breastfeeding
Breastfeeding women
Pregnant or breastfeeding
Women who are breastfeeding are not eligible for this study.
Women who are breastfeeding, pregnant, or planning pregnancy within the next year
Pregnant or breastfeeding
Pregnant, contemplating getting pregnant, or breastfeeding
For women, current pregnancy or breastfeeding or plan to become pregnant during the next 2 months.
Pregnant or breastfeeding.
Current breastfeeding
Pregnant or breastfeeding
Pregnant or breastfeeding
Breastfeeding
Is pregnant, intends to become pregnant during study, or is breastfeeding
Pregnant and/or breastfeeding
Breastfeeding women
Pregnant or breastfeeding
Pregnant or breastfeeding
No breastfeeding
Pregnant, contemplating getting pregnant, or breastfeeding
Pregnant or breastfeeding
men and non-pregnant, non-breastfeeding women
Pregnant or breastfeeding.
Women who are breastfeeding
Women must not be breastfeeding
Pregnant or breastfeeding
Pregnant or breastfeeding
Pregnant or breastfeeding women
Pregnant or breastfeeding
Breastfeeding
Pregnant or breastfeeding
Not pregnant and/or breastfeeding
Pregnant or breastfeeding.
Patient must NOT be breastfeeding.
Female patients who are pregnant or breastfeeding
Pregnant or breastfeeding women
Not pregnant and/or breastfeeding
Women who are pregnant or breastfeeding
Pregnant and breastfeeding patients
Women who are pregnant or breastfeeding
Women who are pregnant or breastfeeding
Participants who are breastfeeding are excluded
Women must not be pregnant nor breastfeeding
Women who are breastfeeding
Pregnant or breastfeeding
Pregnant or breastfeeding
Pregnant and breastfeeding patients
Patient who is pregnant and/or breastfeeding
Pregnant or breastfeeding
Pregnant and/or breastfeeding
Patient must not be pregnant or breastfeeding
Patient must not be pregnant or breastfeeding
Patient must not be pregnant or breastfeeding
Women who are pregnant or breastfeeding
Pregnant or breastfeeding females.
Is pregnant or breastfeeding
Pregnant and/or breastfeeding women.
Female patients who are pregnant or actively breastfeeding
Pregnant or breastfeeding
Not pregnant, not breastfeeding
You are pregnant or breastfeeding
Pregnant or breastfeeding
Women who are pregnant or breastfeeding
Pregnant or breastfeeding at time of consent
NORMAL VOLUNTEERS: If female, pregnant or breastfeeding at time of consent
Breastfeeding
Women who are pregnant or breastfeeding
Pregnant and breastfeeding women are excluded from this study
Patient is pregnant or breastfeeding
Patient must not be pregnant or breastfeeding
Females who are breastfeeding or pregnant.
Patients who are pregnant or breastfeeding
Participants who are breastfeeding, pregnant or trying to become pregnant
Breastfeeding, pregnant, or likely to become pregnant during the study
Pregnant or breastfeeding
Pregnant or breastfeeding, or planning to become pregnant.
Patients may not be pregnant or breastfeeding
For female participants: being pregnant or breastfeeding, or planning to become pregnant, by self-report
Pregnancy or uninterruptible breastfeeding. Pregnancy is an absolute contraindication under this protocol. Women who are breastfeeding must be willing and able to interrupt breastfeeding during the administration of filgrastim and for two days following the final dose.
Women must not be breastfeeding
Patients who are pregnant or breastfeeding or likely to become pregnant
pregnant or breastfeeding
not pregnant, breastfeeding, or planning to become pregnant
Women of childbearing potential who are pregnant or breastfeeding
Female subject who is pregnant or breastfeeding, or planning to become pregnant within 30 days after ending treatment
Women who are pregnant or breastfeeding.
Participants must not be known to be pregnant or breastfeeding
Women who are pregnant or breastfeeding.
Women of childbearing potential who are pregnant or breastfeeding
Pregnant women and women who are breastfeeding are excluded from this study
Females who are pregnant or breastfeeding.
Pregnant or breastfeeding women.
